The global left atrial appendage closure (LAAC) devices market is projected to register a robust growth from 2025 to 2033.

CHICAGO -- For patients at high risk of stroke who underwent catheter-based atrial fibrillation ablation, left atrial appendage closure led to less bleeding compared with oral anticoagulation, the ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Please provide your email address to receive an email when new articles are posted on . OPTION is a head-to-head trial of left atrial appendage closure with Watchman FLX vs. anticoagulation after ...

Researchers have found in a new study that the novel Lesifter device shows encouraging early efficacy and a favorable safety profile in reducing stroke risk among patients with atrial ...

Please provide your email address to receive an email when new articles are posted on . A post hoc analysis of the MESA cohort study shows left atrial scarring seen on MRI may predict incident atrial ...

Medtronic has launched a heart implant designed to help lower the lifetime risk of stroke in people with atrial fibrillation and to serve as a valuable addition to patients who are already undergoing ...